Medius provides an unrivalled range of specialised business development training solutions to cater for all levels of learning. This range extends from client specific in house tutorials through open enrolment courses to the Pharmaceutical Licensing Group’s distance learning modular MSc course.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
White Papers and Resources | March 31, 2014 | Havas Lynx
Unlocking better outcomes in healthcare with UX
White Papers and Resources | January 3, 2014 | Havas Lynx
Better for patients, better for business
White Papers and Resources | January 3, 2014 | Havas Lynx
Our point of view
White Papers and Resources | January 3, 2014 | Havas Lynx
The case to embrace going social
White Papers and Resources | January 3, 2014 | Havas Lynx
Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...
White Papers and Resources | December 19, 2013 | Inizio
A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...
White Papers and Resources | December 19, 2013 | Inizio
Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.
White Papers and Resources | November 22, 2013 | Inizio
How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...
White Papers and Resources | November 22, 2013 | Inizio
Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...
White Papers and Resources | November 22, 2013 | Inizio
This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.